Aura Biosciences (AURA) Enterprise Value (2020 - 2026)
Aura Biosciences' (AURA) quarterly Enterprise Value came in at -$84.8 million in Q1 2026, down 121.82% YoY from $388.6 million in Q1 2025, and down 42.47% on a QoQ basis from -$59.5 million in Q4 2025.
Aura Biosciences (AURA) Enterprise Value (2020 - 2026) Analysis & Trends
Aura Biosciences (AURA) has 7 years of Enterprise Value data on file, last reported at -$84.8 million in Q1 2026.
- Quarterly Enterprise Value fell 121.82% year-over-year to -$84.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$84.8 million (down 121.82% YoY) and the FY2025 annual result came in at -$59.5 million, down 87.79% from the prior year.
- Enterprise Value retreated to -$84.8 million in Q1 2026, from -$59.5 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$20000.0 in Q4 2022 to a low of -$107.4 million in Q2 2025.
- A 5-year average of -$38.5 million and a median of -$38.2 million in 2025 frame the typical range for Enterprise Value.
- The widest YoY moves for Enterprise Value: up 99.99% in 2022, down 305450.0% in 2022.
- Tracing AURA's Enterprise Value over 5 years: stood at -$20000.0 in 2022, then tumbled by 205215.0% to -$41.1 million in 2023, then rose by 22.82% to -$31.7 million in 2024, then slumped by 87.79% to -$59.5 million in 2025, then sank by 42.47% to -$84.8 million in 2026.
- The last three Enterprise Value figures came in at -$84.8 million (Q1 2026), -$59.5 million (Q4 2025), and -$47.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Aura Biosciences | 797.49 Mn | 729.65 Mn | - | -67.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -67.84 Mn |
| Mar 31, 2026 | -84.79 Mn |
| Dec 31, 2025 | -59.52 Mn |
| Sep 30, 2025 | -47.55 Mn |
| Jun 30, 2025 | -107.37 Mn |
| Mar 31, 2025 | -38.23 Mn |
| Dec 31, 2024 | -31.69 Mn |
| Sep 30, 2024 | -25.41 Mn |
| Jun 30, 2024 | -30.08 Mn |
| Mar 31, 2024 | -26.28 Mn |
| Dec 31, 2023 | -41.06 Mn |
| Sep 30, 2023 | -20,000.00 |
| Jun 30, 2023 | -47.73 Mn |
| Mar 31, 2023 | -20,000.00 |
| Dec 31, 2022 | -20,000.00 |
| Sep 30, 2022 | -61.11 Mn |
| Jun 30, 2022 | -53.85 Mn |
| Mar 31, 2022 | -23,000.00 |
| Dec 31, 2021 | -149.06 Mn |
| Sep 30, 2021 | -20,000.00 |